Administrative Core
Administrative Core
批准号:
10159118
负责人:
Deborah J Anderson
金额:
$51.52万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-14 至 2022-08-31
关键词:
AchievementAdherenceAntibodiesAntigen TargetingAwardBiologicalBiological ProductsBloodBostonClinicalClinical ManagementClinical ResearchCommunicationContraceptive AgentsContraceptive methodsDataDatabase Management SystemsDevelopmentExperimental DesignsFilmFosteringGoalsGrantGrant ReviewGuidelinesHIV-1HumanImmobilizationIndividualIndustrializationInfertilityInfrastructureLeadershipLibrariesLiquid substanceLouisianaMethodsMonitorMonoclonal AntibodiesNorth CarolinaPhase I Clinical TrialsPreventionPrimatesProgram ReviewsPublicationsReagentResearchResearch PersonnelResearch Project GrantsResource AllocationResource SharingScheduleScientistSexually Transmitted DiseasesSimplexvirusSpermatozoa antibodyStatistical Data InterpretationSurfaceTechnologyTestingTopical applicationUnited States National Institutes of HealthUniversitiesVaginal RingVaginal Route of Drug AdministrationVirginiaWomanbasecareerclinical databasedata acquisitiondata managementdata sharingexperienceinterestmedical schoolsmeetingspathogenpre-clinical researchprogramssperm cellstatisticssuccesssymposiumweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ADMINISTRATIVE CORE: ABSTRACT
The Contraception Research Center at Boston University School of Medicine (BUSM-CRC) brings together an
experienced team of clinical, industrial and basic scientists to develop and test new contraceptive products
based on topical administration of Human Contraceptive Antibody (HCA). HCA was originally isolated from the
blood of an infertile but otherwise healthy woman. The antibody targets an antigen on the surface of human
sperm and can agglutinate/immobilize sperm within seconds. We propose to release HCA monoclonal antibodies
from a quick-dissolving film for short-term (on demand) protection, and from an intravaginal ring (IVR) for
protection lasting up to one month. Our long term goal is to combine HCA with antibodies against pathogens
such as HIV-1 and HSV that cause serious sexually-transmitted infections (STIs), to provide a new multipurpose
prevention technology (MPT) platform that delivers both contraception and protection against STIs.
Success of the BUSM-CRC will rely upon an Administrative Core that will provide scientific and administrative
leadership in coordinating the three developmental and translational Projects that make up the program. The
Administrative Core will also coordinate data and materials acquisition and sharing so that the research
progresses in an integrated iterative fashion to meet individual project and programmatic milestones, and foster
the development of junior scientists interested in pusuing a career in contraception/MPT research.
The Specific Aims of the Administrative Core are:
1. To provide scientific leadership and administrative oversight. Specifically, the Administrative Core will
establish an Executive Committee (EC) for ongoing assessment of project and core milestones, resource
allocation and changes to the experimental design. The Administrative Core will also convene an external
Scientific Advisory Panel (SAP) to review the program in years 2 and 4. The Administrative Core will facilitate
communication through scheduled conference calls and investigator meetings, provide financial and
administrative support, and insure adherence to institutional and federal guidelines
2. To coordinate data and materials acquisition and sharing to insure that project and program
milestones are met. The Administrative Core will be responsible for the reagent/research material and data
management and sharing plan, and for monitoring milestone achievements.
3. To manage the clinical database and statistical analysis for the two Phase 1 clinical trials.
4. To award pilot grants to encourage junior and other scientists to enter the contraception/MPT field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synthetic mRNA-mediated reversible immunocontraception
-
批准号:10018523
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2019
-
负责人:Deborah J Anderson
-
依托单位:
Synthetic mRNA-mediated reversible immunocontraception
-
批准号:10474919
-
项目类别:
-
资助金额:$68.75万
-
财政年份:2019
-
负责人:Deborah J Anderson
-
依托单位:
Core A: Administration
-
批准号:10532091
-
项目类别:
-
资助金额:$21.26万
-
财政年份:2018
-
负责人:Deborah J Anderson
-
依托单位:
Preclinical Testing of Human Contraceptive Antibody (HCA) and HCA products
-
批准号:10159120
-
项目类别:
-
资助金额:$39.97万
-
财政年份:2018
-
负责人:Deborah J Anderson
-
依托单位:
Antibody-based Contraceptive MPTs: Advancing the Human Contraceptive Antibody (HCA) through Clinical Trials
-
批准号:10532090
-
项目类别:
-
资助金额:$171.54万
-
财政年份:2018
-
负责人:Deborah J Anderson
-
依托单位:
Antibody-based Contraceptive MPTs: Preclinical and Clinical Research
-
批准号:10159117
-
项目类别:
-
资助金额:$181.36万
-
财政年份:2018
-
负责人:Deborah J Anderson
-
依托单位:
Project 3: Film Formulation, PK/PD and Safety Studies of ZB-06
-
批准号:10532094
-
项目类别:
-
资助金额:$45.11万
-
财政年份:2018
-
负责人:Deborah J Anderson
-
依托单位:
Project Three: Assessing effects of anti-CD52g Mabs on STD pathogens in semen
-
批准号:9977700
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2017
-
负责人:Deborah J Anderson
-
依托单位:
Project One: Development and Testing of the HCA IVR
-
批准号:9548350
-
项目类别:
-
资助金额:$79.02万
-
财政年份:2017
-
负责人:Deborah J Anderson
-
依托单位:
Seminal Microbiota Associated with Inflammation and HIV Transmission
-
批准号:9221010
-
项目类别:
-
资助金额:$24.68万
-
财政年份:2016
-
负责人:Deborah J Anderson
-
依托单位:
Administrative Core
-
批准号:8900903
-
项目类别:
-
资助金额:$67.73万
-
财政年份:2015
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8803840
-
项目类别:
-
资助金额:$2.72万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8302296
-
项目类别:
-
资助金额:$357.38万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8900899
-
项目类别:
-
资助金额:$240.83万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8706772
-
项目类别:
-
资助金额:$253.06万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Administrative Core
-
批准号:8209673
-
项目类别:
-
资助金额:$14.25万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8193671
-
项目类别:
-
资助金额:$303.32万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
MAbs in the Cervicovaginal Environment: Cellular Interactions and Host Defense
-
批准号:8209659
-
项目类别:
-
资助金额:$22.87万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8515314
-
项目类别:
-
资助金额:$309.83万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8435056
-
项目类别:
-
资助金额:$2.61万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
海外基金